Search

everythinglearnresearchcommunity

for

Search:↓

Blue light might help treat skin conditions by affecting the skin's bacteria.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Apoptosis is crucial for healthy skin and treating skin diseases.

Long-COVID has diverse, long-term health impacts, especially in young people.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

Removing the outer layer of skin cells from hair grafts does not change the graft survival rate but may improve how it looks right after surgery.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

A woman was misdiagnosed with hair loss for years, but actually had a rare type of alopecia.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

Potassium levels affect blood sugar and insulin during dialysis, and malnutrition changes children's hair roots.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Sandalore® improves hair growth and quality in people with hair loss.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Normal hair density and diameter ratios were established to help diagnose adult hair loss.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.